UNIQURE NV's ticker is QURE and the CUSIP is N90064101. A total of 160 filers reported holding UNIQURE NV in Q3 2023. The put-call ratio across all filers is 0.45 and the average weighting 0.1%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,512,661 | -45.6% | 374,465 | -7.1% | 0.00% | 0.0% |
| Q2 2023 | $4,621,086 | -47.8% | 403,236 | -8.2% | 0.00% | -66.7% |
| Q1 2023 | $8,847,481 | -14.3% | 439,299 | -3.5% | 0.00% | -25.0% |
| Q4 2022 | $10,321,000 | +8.9% | 455,281 | -9.9% | 0.00% | 0.0% |
| Q3 2022 | $9,477,000 | +6.1% | 505,165 | +5.4% | 0.00% | +33.3% |
| Q2 2022 | $8,934,000 | +1.4% | 479,248 | -1.7% | 0.00% | 0.0% |
| Q1 2022 | $8,811,000 | +172.2% | 487,619 | +212.4% | 0.00% | +200.0% |
| Q4 2021 | $3,237,000 | -79.9% | 156,110 | -68.9% | 0.00% | -80.0% |
| Q3 2021 | $16,069,000 | +132.5% | 502,001 | +123.7% | 0.01% | +150.0% |
| Q2 2021 | $6,911,000 | -8.9% | 224,391 | -0.4% | 0.00% | -33.3% |
| Q1 2021 | $7,588,000 | -47.3% | 225,230 | -43.4% | 0.00% | -40.0% |
| Q4 2020 | $14,391,000 | +197.0% | 398,278 | +202.7% | 0.01% | +150.0% |
| Q3 2020 | $4,845,000 | -18.6% | 131,560 | -0.4% | 0.00% | -33.3% |
| Q2 2020 | $5,950,000 | +55.8% | 132,044 | +64.0% | 0.00% | +50.0% |
| Q1 2020 | $3,819,000 | -28.4% | 80,509 | +8.1% | 0.00% | 0.0% |
| Q4 2019 | $5,336,000 | +144.4% | 74,456 | +34.2% | 0.00% | +100.0% |
| Q3 2019 | $2,183,000 | -58.1% | 55,487 | -16.9% | 0.00% | -50.0% |
| Q2 2019 | $5,214,000 | -1.8% | 66,734 | -25.1% | 0.00% | 0.0% |
| Q1 2019 | $5,311,000 | +34.6% | 89,047 | -35.0% | 0.00% | 0.0% |
| Q4 2018 | $3,946,000 | -28.3% | 136,942 | -9.5% | 0.00% | 0.0% |
| Q3 2018 | $5,506,000 | -1.3% | 151,297 | +2.5% | 0.00% | 0.0% |
| Q2 2018 | $5,581,000 | +368.2% | 147,670 | +191.0% | 0.00% | +100.0% |
| Q1 2018 | $1,192,000 | -11.3% | 50,741 | -26.0% | 0.00% | 0.0% |
| Q4 2017 | $1,344,000 | +152.2% | 68,570 | +112.9% | 0.00% | – |
| Q4 2015 | $533,000 | -19.2% | 32,205 | -0.2% | 0.00% | – |
| Q3 2015 | $660,000 | +16.2% | 32,271 | +53.4% | 0.00% | – |
| Q2 2015 | $568,000 | – | 21,034 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 155,500 | $11,803,000 | 2.66% |
| Aquilo Capital Management, LLC | 901,490 | $16,290,000 | 2.39% |
| Nantahala Capital Management | 2,811,459 | $50,803,000 | 2.25% |
| Privium Fund Management B.V. | 493,229 | $8,913,000 | 1.97% |
| 683 Capital Management, LLC | 1,355,000 | $24,485,000 | 1.31% |
| Henry James International Management Inc. | 125,622 | $2,270,000 | 0.90% |
| Integral Health Asset Management, LLC | 170,000 | $3,072,000 | 0.80% |
| Nantahala Capital Management | 890,000 | $16,082,000 | 0.71% |
| Sonic Fund II, L.P. | 50,000 | $904,000 | 0.51% |
| Voss Capital, LLC | 70,000 | $1,265,000 | 0.40% |